Demant ASWILYY 94 ROC (Joel Greenblatt) % is 39.45% as of Dec. 2025, which is 23% below its 10-year median of 51.25. GuruFocus rates WILYY with a GF Score™ of 94/100 and a GF Value™ of $23.74 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 840 Medical Devices & Instruments companies, Demant AS ranks better than 85.71% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Demant AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 39.45%.
The historical rank and industry rank for Demant AS's ROC (Joel Greenblatt) % or its related term are showing as below:
WILYY'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 23.49 Med: 51.25 Max: 64.24
Current: 41.38
During the past 13 years, Demant AS's highest ROC (Joel Greenblatt) % was 64.24%. The lowest was 23.49%. And the median was 51.25%.
WILYY's ROC (Joel Greenblatt) % is ranked better than 85.71% of 840
companies
in the Medical Devices & Instruments industry
Industry Median: 4.035
vs WILYY: 41.38
Demant AS's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 7.80% per year.
Demant AS (OTCPK:WILYY) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
The historical data trend for Demant AS's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WILYY vs ABT, SYK, MDT: ROC (Joel Greenblatt) % Comparison
For the Medical Devices subindustry, Demant AS's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Demant AS ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Demant AS's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Demant AS's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 39.45% mean?
Demant AS (WILYY) has a ROC (Joel Greenblatt) % of 39.45% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Demant AS and its competitors. This is 23% below median its historical median of 51.25. Over the past decade, Demant AS's ROC (Joel Greenblatt) % has ranged from 23.49 to 64.24. According to the industry distribution chart, Demant AS ranks #120 out of 840 companies in the Medical Devices & Instruments industry, placing it in the top 14.3%.
Is Demant AS's ROC (Joel Greenblatt) % too high?
Demant AS's current ROC (Joel Greenblatt) % of 39.45% is 23% below median its 10-year median of 51.25. Over the past 10 years, this metric has ranged from a low of 23.49 to a high of 64.24. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.04. Demant AS's value of 39.45% is 877.7% above this industry median. Based on the distribution chart, Demant AS ranks #120 out of 840 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Demant AS has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Demant AS's ROC (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Demant AS ranks #120 out of 840 companies for ROC (Joel Greenblatt) %. This places Demant AS in the top 14% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 4.04. Demant AS's value of 39.45% is 877.7% above this benchmark. Historically, Demant AS's own ROC (Joel Greenblatt) % has ranged from 23.49 to 64.24 over the past decade. While the company's 10-year median is 51.25 vs. the industry median of 4.04, Demant AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.04, based on 840 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Demant AS's current ROC (Joel Greenblatt) % of 39.45% is 877.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Demant AS and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Demant AS's current ROC (Joel Greenblatt) % is 39.45%, which is 23% below median its own 10-year median of 51.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Demant AS stock overvalued right now?
Based on GuruFocus' analysis, Demant AS (WILYY) is currently considered Modestly Undervalued. The stock's GF Value™ is $23.74, compared to a current price of $20.66 — trading 13% below its estimated fair value. The current ROC (Joel Greenblatt) % is 39.45%, which is 23% below median its 10-year median of 51.25 and 877.7% above the Medical Devices & Instruments industry median of 4.04. Demant AS's overall GF Score™ is 94/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Demant AS (WILYY), the current ROC (Joel Greenblatt) % is 39.45% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Demant AS (WILYY) Overvalued in 2026?
Based on GuruFocus' analysis, Demant AS stock appears to be undervalued.
The current stock price of $20.66 is trading 13% below its estimated GF Value™ of $23.74.
GuruFocus considers Demant AS to be Modestly Undervalued.
Key valuation signals for WILYY:
ROC (Joel Greenblatt) %: 39.45% (23% below median its 10-year median of 51.25)
GF Value™: $23.74 vs. price of $20.66 (13% below fair value)
Industry Position: 877.7% above the Medical Devices & Instruments median (#120 of 840)
No single metric tells the full story. See the WILYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Demant is a Denmark-based manufacturer and distributor of hearing solutions, such as hearing aid devices and diagnostic equipment. More than 80% of the company's sales come from North America and Europe.
94GF Score
Get the complete analysis for WILYY
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WILYY has been successfully added to your 
